BASF's China Venture Faces Profitability Delay Amid Market Pressures

BASF's major Zhanjiang site faces profitability delays due to Asian market overcapacity, impacting shares. The firm defends its China strategy and boosts shareholder returns via dividends and buybacks.

Investors in BASF SE will need to exercise greater patience as the chemical giant's most expensive overseas project to date encounters headwinds. CEO Markus Kamieth acknowledged over the weekend that the new integrated production site in Zhanjiang, China, will take longer than initially projected to become profitable. The delay is primarily attributed to persistent overcapacity and historically low profit margins within the Asian chemical market, factors which are significantly hampering the launch of the multi-billion euro facility.

Share Performance Reflects Cautious Outlook

The market's reaction to this tempered guidance has been negative. BASF shares closed at €45.34 this past Friday, marking a weekly decline of 6.23%. This drop pushed the stock below its 50-day moving average, indicating recent selling pressure fueled by the revised expectations for the Chinese operation.

Financially, the DAX-listed group anticipates an adjusted EBITDA for 2026 to land between €6.2 billion and €7.0 billion. When measured against the previous year's result of €6.6 billion, this forecast points to a corporate expectation of, at best, a modestly positive performance. The company is relying on its Nutrition & Care and Chemicals divisions to provide underlying support.

Management Defends Strategic China Commitment

Despite the challenging start, BASF's leadership is staunchly defending the investment, which carries a price tag of up to €10 billion. Exiting the Chinese market—which represents approximately half of the global chemical sector—is viewed as a greater long-term threat to competitiveness than the current initial losses. Stephan Kothrade, head of the Asia operations, emphasized that while the site's production ramp-up is proceeding slower than planned, BASF remains cost-competitive even at the currently depressed price levels.

Capital Returns Provide Counterbalance

To offset these operational challenges, BASF is emphasizing shareholder returns. The board will propose a dividend of €2.25 per share at the Annual Meeting on April 30. Concurrently, the company is supporting its share price through an ongoing buyback initiative. As part of its €4 billion repurchase program running through 2028, BASF acquired nearly 900,000 of its own shares in the second week of March alone.

The scheduled dividend payment on May 6 will provide investors with a fixed capital return while they await a potential fundamental recovery. However, analysts suggest a sustained reversal in the equity's trend now requires concrete positive signals from Asia. As long as import pressure remains high in Europe and overcapacity in China's chemical industry persists, difficult geopolitical and market conditions are likely to limit the stock's upside potential.